These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone. Merkel C, Sacerdoti D, Bolognesi M, Enzo E, Marin R, Bombonato G, Angeli P, Gatta A. Hepatology; 1997 Jul; 26(1):34-9. PubMed ID: 9214449 [Abstract] [Full Text] [Related]
26. [Isosorbide-5-mononitrate (mono mac) in the prevention of bleeding from esophageal varicose veins in patients with liver cirrhosis]. Abdurakhmanov DT. Klin Med (Mosk); 2001 Jul; 79(2):60-2. PubMed ID: 11419092 [Abstract] [Full Text] [Related]
28. Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: a meta-analysis of randomized controlled trials. Bai M, Qi X, Yang M, Han G, Fan D. J Gastroenterol Hepatol; 2014 Mar; 29(3):442-52. PubMed ID: 24118091 [Abstract] [Full Text] [Related]
31. Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding. Laleman W, Nevens F. Minerva Med; 2006 Aug; 97(4):325-45. PubMed ID: 17008837 [Abstract] [Full Text] [Related]
32. Management of cirrhosis and ascites. Bhaskar ME. N Engl J Med; 2004 Jul 15; 351(3):300-1; author reply 300-1. PubMed ID: 15257569 [No Abstract] [Full Text] [Related]
33. Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence. Kumar A, Jha SK, Sharma P, Dubey S, Tyagi P, Sharma BC, Sarin SK. Gastroenterology; 2009 Sep 15; 137(3):892-901, 901.e1. PubMed ID: 19481079 [Abstract] [Full Text] [Related]
34. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy. Sauerbruch T, Mengel M, Dollinger M, Zipprich A, Rössle M, Panther E, Wiest R, Caca K, Hoffmeister A, Lutz H, Schoo R, Lorenzen H, Trebicka J, Appenrodt B, Schepke M, Fimmers R, German Study Group for Prophylaxis of Variceal Rebleeding. Gastroenterology; 2015 Sep 15; 149(3):660-8.e1. PubMed ID: 25989386 [Abstract] [Full Text] [Related]
39. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis. Roccarina D, Best LM, Freeman SC, Roberts D, Cooper NJ, Sutton AJ, Benmassaoud A, Plaz Torres MC, Iogna Prat L, Csenar M, Arunan S, Begum T, Milne EJ, Tapp M, Pavlov CS, Davidson BR, Tsochatzis E, Williams NR, Gurusamy KS. Cochrane Database Syst Rev; 2021 Apr 06; 4(4):CD013121. PubMed ID: 33822357 [Abstract] [Full Text] [Related]
40. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study. Abecasis R, Kravetz D, Fassio E, Ameigeiras B, Garcia D, Isla R, Landeira G, Dominguez N, Romero G, Argonz J, Terg R. Hepatology; 2003 Feb 06; 37(2):359-65. PubMed ID: 12540786 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]